Login / Signup

COVID-19 infection risk in patients on immunosuppressive/immunomodulator therapy: A single center study.

Maryam GhiasiMaryam NasimiNarges GhandiVahideh LajevardiRobabeh AbediniArghavan AzizpourMahshid Sadat AnsariAzita KheiltashKamran Balighi
Published in: Dermatologic therapy (2021)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • stem cells
  • bone marrow
  • patient reported
  • cell therapy
  • smoking cessation